肾癌-话题@MedSci

#肾癌#

9篇内容 | 2980人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2226849, encodeId=18e82226849ec, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=293711933581' target=_blank style='color:#2F92EE;'>#TFEB融合#</a> <a href='/topic/show?id=c65b11933694' target=_blank style='color:#2F92EE;'>#RNA-NGS#</a>, objectTitle=“绘”解读真报告丨肾癌患者精准检出TFEB融合，RNA-NGS助力临床病理分型！, objectType=article, longId=843999, objectId=bd8f843999ef, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240920/1726797596079_8538692.jpg, objectUrl=/article/show_article.do?id=bd8f843999ef, replyNumber=0, likeNumber=27, createdTime=2024-09-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bd8f843999ef, moduleTitle=“绘”解读真报告丨肾癌患者精准检出TFEB融合，RNA-NGS助力临床病理分型！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd8f843999ef)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222627, encodeId=0dce222262e8b, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=fda910921003' target=_blank style='color:#2F92EE;'>#慢性肾脏病（CKD）#</a>, objectTitle=CKJ：糖尿病肾病加痛风，肾癌发生风险会更高吗？, objectType=article, longId=840722, objectId=468e840e22c2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240730/1722324976987_92910.jpg, objectUrl=/article/show_article.do?id=468e840e22c2, replyNumber=0, likeNumber=90, createdTime=2024-08-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=468e840e22c2, moduleTitle=CKJ：糖尿病肾病加痛风，肾癌发生风险会更高吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468e840e22c2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221493, encodeId=9ec822214932c, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=d31ce7585bb' target=_blank style='color:#2F92EE;'>#线粒体功能#</a>, objectTitle=最新Nature：线粒体复合体I会促进肾癌转移, objectType=article, longId=839731, objectId=6bc5839e317c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240707/1720364279444_5579292.png, objectUrl=/article/show_article.do?id=6bc5839e317c, replyNumber=0, likeNumber=61, createdTime=2024-08-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6bc5839e317c, moduleTitle=最新Nature：线粒体复合体I会促进肾癌转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bc5839e317c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221060, encodeId=d2a52221060b9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=6d4f8232623' target=_blank style='color:#2F92EE;'>#肺转移#</a> <a href='/topic/show?id=494711e1314f' target=_blank style='color:#2F92EE;'>#线粒体电子传递链#</a>, objectTitle=Nature：挑战常规！激活线粒体代谢可促进肾癌转移, objectType=article, longId=839433, objectId=43c0839433b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240818/1723938542143_2185383.png, objectUrl=/article/show_article.do?id=43c0839433b1, replyNumber=0, likeNumber=66, createdTime=2024-08-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207074, encodeId=639e220e0747a, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a>, objectTitle=大咖谈 | 中国晚期肾癌患者免疫治疗进展, objectType=article, longId=827638, objectId=254082e63853, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240528/1716883349790_5579292.jpg, objectUrl=/article/show_article.do?id=254082e63853, replyNumber=0, likeNumber=94, createdTime=2024-05-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=254082e63853, moduleTitle=大咖谈 | 中国晚期肾癌患者免疫治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=254082e63853)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2204651, encodeId=808c22046518c, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=42e6114456f2' target=_blank style='color:#2F92EE;'>#SBS40b#</a> <a href='/topic/show?id=201e11445ed2' target=_blank style='color:#2F92EE;'>#诱变因子#</a>, objectTitle=Nature：新研究指出一种未知的致癌诱变因子——SBS40b，其与一些国家的肾癌高发有关, objectType=article, longId=825543, objectId=92c382554333, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240512/1715509356230_2185383.png, objectUrl=/article/show_article.do?id=92c382554333, replyNumber=0, likeNumber=57, createdTime=2024-05-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197741, encodeId=c314219e741c3, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=e4cb6612395' target=_blank style='color:#2F92EE;'>#深度学习#</a>, objectTitle=European Radiology：基于CT的深度学习放射组学列线图在透明细胞肾癌患者预后预测方面的价值, objectType=article, longId=820913, objectId=051582091322, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230321/1679467039567_4754896.jpeg, objectUrl=/article/show_article.do?id=051582091322, replyNumber=0, likeNumber=102, createdTime=2024-04-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=051582091322, moduleTitle=European Radiology：基于CT的深度学习放射组学列线图在透明细胞肾癌患者预后预测方面的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=051582091322)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2186668, encodeId=9626218666869, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=56b0194220e' target=_blank style='color:#2F92EE;'>#一线治疗#</a> <a href='/topic/show?id=e3258513293' target=_blank style='color:#2F92EE;'>#脑转移患者#</a>, objectTitle=Eur. Urol：接受一线治疗的肾细胞癌脑转移患者的结果：国际转移性肾细胞癌数据库联盟的结果, objectType=article, longId=812841, objectId=f0798128411e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240208/1707406953133_6145188.jpg, objectUrl=/article/show_article.do?id=f0798128411e, replyNumber=0, likeNumber=0, createdTime=2024-02-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f0798128411e, moduleTitle=Eur. Urol：接受一线治疗的肾细胞癌脑转移患者的结果：国际转移性肾细胞癌数据库联盟的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0798128411e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2185380, encodeId=8c3d21853800a, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=Eur J Radiol：肿瘤轮廓不规则对肾癌手术策略的预后价值, objectType=article, longId=811900, objectId=ffb0811900b8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240201/1706795275986_1605392.png, objectUrl=/article/show_article.do?id=ffb0811900b8, replyNumber=0, likeNumber=158, createdTime=2024-02-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ffb0811900b8, moduleTitle=Eur J Radiol：肿瘤轮廓不规则对肾癌手术策略的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffb0811900b8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184496, encodeId=5dbf218449665, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=8d16999eda' target=_blank style='color:#2F92EE;'>#Ipilimumab#</a> <a href='/topic/show?id=30fc1282896' target=_blank style='color:#2F92EE;'>#Nivolumab#</a> <a href='/topic/show?id=c193110640f1' target=_blank style='color:#2F92EE;'>#ASCO GU 2024#</a>, objectTitle=ASCO GU 2024：Nivolumab/Ipilimumab在未经治疗的晚期或转移性RCC患者中显示出显著的生存获益（CheckMate-214研究）, objectType=article, longId=811385, objectId=df7281138559, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240128/1706443016945_8624274.png, objectUrl=/article/show_article.do?id=df7281138559, replyNumber=0, likeNumber=105, createdTime=2024-01-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=df7281138559, moduleTitle=ASCO GU 2024：Nivolumab/Ipilimumab在未经治疗的晚期或转移性RCC患者中显示出显著的生存获益（CheckMate-214研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df7281138559)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2169938, encodeId=97502169938aa, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a> <a href='/topic/show?id=3c1630303e' target=_blank style='color:#2F92EE;'>#avelumab#</a> <a href='/topic/show?id=07bc1e1148a' target=_blank style='color:#2F92EE;'>#talazoparib#</a>, objectTitle=Eur Urol Oncol：Talazoparib和Avelumab治疗转移性肾癌的 2 期试验结果, objectType=article, longId=801712, objectId=37af801e12ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231121/1700533328624_1935437.jpg, objectUrl=/article/show_article.do?id=37af801e12ca, replyNumber=0, likeNumber=114, createdTime=2023-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=37af801e12ca, moduleTitle=Eur Urol Oncol：Talazoparib和Avelumab治疗转移性肾癌的 2 期试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37af801e12ca)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2165501, encodeId=8e5c21655010d, content=<a href='/topic/show?id=13c5394250a' target=_blank style='color:#2F92EE;'>#吸烟#</a>与<a href='/topic/show?id=8fc053e3768' target=_blank style='color:#2F92EE;'>#慢性鼻炎#</a>、<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>、<a href='/topic/show?id=ef79e2987a2' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=ef79e2987a2' target=_blank style='color:#2F92EE;'>#睡眠呼吸暂停#</a></a>、头颈部溃疡、<a href='/topic/show?id=ccc9392453c' target=_blank style='color:#2F92EE;'>#听力损失#</a>等耳鼻喉科疾病的发病风险呈正相关，与<a href='/topic/show?id=bec66989e9a' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=bec66989e9a' target=_blank style='color:#2F92EE;'>#甲状腺癌#</a></a>呈负相关。然而，吸烟对其他耳鼻喉科疾病影响的证据还很有限。此外，大量<a href='/topic/show?id=c37e1012082d' target=_blank style='color:#2F92EE;'>#饮酒#</a>会增加多种耳鼻咽喉科疾病的风险，包括<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>、<a href='/topic/show?id=ef79e2987a2' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=ef79e2987a2' target=_blank style='color:#2F92EE;'>#睡眠呼吸暂停#</a></a>和听力损失；而中度饮酒与甲状腺癌的发病率呈负相关。不过，甲状腺癌是很特殊的，吸烟和饮酒竟然与它负相关，但是值得注意的是<a href='/topic/show?id=ecff10e2817b' target=_blank style='color:#2F92EE;'>#不粘锅#</a>与甲状腺癌密切相关。不粘锅中<a href='/topic/show?id=686f294e494' target=_blank style='color:#2F92EE;'>#全氟烷基物质#</a>和<a href='/topic/show?id=d09f10e282fc' target=_blank style='color:#2F92EE;'>#多氟烷基物质#</a>(PFAS)是主要成分，包括常见的<a href='/topic/show?id=295610e2836f' target=_blank style='color:#2F92EE;'>#特氟龙#</a>涂层（<a href='/topic/show?id=e99410e284b7' target=_blank style='color:#2F92EE;'>#聚四氟乙烯#</a>），可能与<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>、<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>、<a href='/topic/show?id=bec66989e9a' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=bec66989e9a' target=_blank style='color:#2F92EE;'>#甲状腺癌#</a></a>等多种癌症密切相关。, objectTitle=Eur Arch Otorhinolaryngol：吸烟和饮酒与 11 种常见耳鼻喉疾病风险的关系：一个双向孟德尔随机化分析, objectType=article, longId=798253, objectId=b249e9825356, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301028/1698454705904_1935437.jpg, objectUrl=/article/show_article.do?id=b249e9825356, replyNumber=0, likeNumber=135, createdTime=2023-10-29, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=b249e9825356, moduleTitle=Eur Arch Otorhinolaryngol：吸烟和饮酒与 11 种常见耳鼻喉疾病风险的关系：一个双向孟德尔随机化分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b249e9825356)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1239853, encodeId=b5fd1239853eb, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=手术是肾癌治疗的首选手段！早期、中期、晚期肾癌患者均可获益, objectType=article, longId=735038, objectId=2cdde3503837, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220806/1659762712879_8252897.webp, objectUrl=/article/show_article.do?id=2cdde3503837, replyNumber=0, likeNumber=133, createdTime=2022-08-20, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdde3503837, moduleTitle=手术是肾癌治疗的首选手段！早期、中期、晚期肾癌患者均可获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdde3503837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214273, encodeId=5bdc12142e3a9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=肾癌基因检测中国专家共识（2021版）, objectType=guider, longId=16736, objectId=3d0911c002a09e6b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=3d0911c002a09e6b, replyNumber=0, likeNumber=158, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d0911c002a09e6b, moduleTitle=肾癌基因检测中国专家共识（2021版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=3d0911c002a09e6b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=2021 CSCO 肾癌诊疗指南, objectType=guider, longId=15569, objectId=42ac51c002293082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=42ac51c002293082, replyNumber=0, likeNumber=147, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42ac51c002293082, moduleTitle=2021 CSCO 肾癌诊疗指南, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=42ac51c002293082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1071675, encodeId=4c5d10e1675b9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=抗肿瘤药物处方审核专家共识：肾癌, objectType=guider, longId=14028, objectId=32e601c002138947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=32e601c002138947, replyNumber=0, likeNumber=168, createdTime=2021-11-19, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32e601c002138947, moduleTitle=抗肿瘤药物处方审核专家共识：肾癌, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=32e601c002138947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=922521, encodeId=853c92252114, content=<a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a>单药一线治疗晚期非透明细胞<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=JCO：帕博利珠单抗单药一线治疗晚期非透明细胞肾癌的客观缓解率可达26.7％, objectType=article, longId=206735, objectId=bdea206e35cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/syringe-injection-by-doctor-PG5KHML.jpg, objectUrl=/article/show_article.do?id=bdea206e35cc, replyNumber=0, likeNumber=230, createdTime=2021-02-03, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdea206e35cc, moduleTitle=JCO：帕博利珠单抗单药一线治疗晚期非透明细胞肾癌的客观缓解率可达26.7％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdea206e35cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916395, encodeId=098b91639510, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610258817277_5295905.jpg, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=285, createdTime=2021-01-14, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916383, encodeId=44df916383e9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a><a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610258817277_5295905.jpg, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=279, createdTime=2021-01-13, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=915874, encodeId=a0a59158e47d, content=<a href='/topic/show?id=fffe10411443' target=_blank style='color:#2F92EE;'>#阿昔替尼联合派姆单抗#</a>＆<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, objectType=article, longId=205645, objectId=b54a2056457f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021111/1610374641055_2110107.JPG, objectUrl=/article/show_article.do?id=b54a2056457f, replyNumber=0, likeNumber=207, createdTime=2021-01-12, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b54a2056457f, moduleTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b54a2056457f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肾癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #TFEB融合# #RNA-NGS#

“绘”解读真报告丨肾癌患者精准检出TFEB融合，RNA-NGS助力临床病理分型！

2024-09-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #慢性肾脏病（CKD）#

CKJ：糖尿病肾病加痛风，肾癌发生风险会更高吗？

2024-08-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #线粒体功能#

最新Nature：线粒体复合体I会促进肾癌转移

2024-08-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #肺转移# #线粒体电子传递链#

2024-08-18发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #免疫治疗#

大咖谈 | 中国晚期肾癌患者免疫治疗进展

2024-05-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #SBS40b# #诱变因子#

2024-05-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #深度学习#

European Radiology：基于CT的深度学习放射组学列线图在透明细胞肾癌患者预后预测方面的价值

2024-04-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #一线治疗# #脑转移患者#

Eur. Urol：接受一线治疗的肾细胞癌脑转移患者的结果：国际转移性肾细胞癌数据库联盟的结果

2024-02-09发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌#

Eur J Radiol：肿瘤轮廓不规则对肾癌手术策略的预后价值

2024-02-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肾癌# #Ipilimumab# #Nivolumab# #ASCO GU 2024#

ASCO GU 2024：Nivolumab/Ipilimumab在未经治疗的晚期或转移性RCC患者中显示出显著的生存获益（CheckMate-214研究）

2024-01-28发表于上海

梅斯管理员 (审核中...)